Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03874624
Other study ID # IIBSP-STR-2018-111
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 22, 2019
Est. completion date May 31, 2019

Study information

Verified date March 2019
Source Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Contact Lidia Bos Real
Phone 0034935537058
Email lbos@santpau.cat
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Transversal retrospective and unicentric study. The investigators sought to determine the normal values for two-dimensional myocardial left atrial strain for the cardiology ultrasound system available in their centre (Philips EPIQ ultrasound machine and 10.8.5 QLAB cardiac analysis software). Studies performed in their department which meet the criteria for an adequate strain analysis will be retrospectively reviewed.


Recruitment information / eligibility

Status Recruiting
Enrollment 43
Est. completion date May 31, 2019
Est. primary completion date May 31, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- No history of cardiopathy / pneumopathy.

- No history of hypertension or mellitus diabetes.

Exclusion Criteria:

- Pregnancy.

- Athletes.

- Body mass index < 16 or => 30 kg/m2.

- Previous treatment with cardiotoxic chemotherapy.

- Dilated left ventricle (telediastolic diameter index > 30 mm/m2).

- Interventricular septal thickness => 12 mm.

- Dilated left atria (volume => 31 ml/m2).

- Systolic pulmonary pressure => 35 mmHg.

- Moderate or severe valvulopathy.

- Incomplete or suboptimal left atrial visualization.

- Frame rate < 50 fps.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
two-dimensional speckle tracking
Analysis of myocardial left atrial strain using two-dimensional speckle tracking echocardiography.

Locations

Country Name City State
Spain Hospital de la Santa Creu i Sant Pau Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Global peak reservoir strain. Percentage of peak reservoir strain for 4-, 2- and 3-chambers will be combined to report percentage of global peak reservoir strain. Through study completion, an average of 4 months.
Primary Global pump strain. Percentage of pump reservoir strain for 4-, 2- and 3-chambers will be combined to report percentage of global pump strain. Through study completion, an average of 4 months.
Primary Global conductance strain. Measured as the difference between global reservoir strain and gobal pump strain. Through study completion, an average of 4 months.
Primary Global reservoir strain rate. Reservoir strain rate for 4-, 2- and 3-chambers will be combined to report global reservoir strain rate. Through study completion, an average of 4 months.
Primary Global conductance strain rate. Conductance strain rate for 4-, 2- and 3-chambers will be combined to report global conductance strain rate. Through study completion, an average of 4 months.
Primary Global pump strain rate. Pump strain rate for 4-, 2- and 3-chambers will be combined to report global pump strain rate. Through study completion, an average of 4 months.
Secondary Age in years Through study completion, an average of 4 months.
Secondary Sex male or female Through study completion, an average of 4 months.
Secondary Weight in kilograms Through study completion, an average of 4 months.
Secondary Height in meters Through study completion, an average of 4 months.
Secondary Left atrial volume Measured by biplanar volumetric method Through study completion, an average of 4 months.
Secondary Left ventricular ejection fraction Measured by biplanar Simpson's method Through study completion, an average of 4 months.
Secondary Left ventricular telediastolic volume Measured by Simpson's method Through study completion, an average of 4 months.
Secondary Left ventricular dimensions Assessed by the following parameters: telediastolic diameter, interventricular septal thickness, posterior wall thickness (in mm) Through study completion, an average of 4 months.
Secondary E/A ratio Transmitral flow profile. Through study completion, an average of 4 months.
Secondary E/e' ratio Tissue doppler derived parameter. Through study completion, an average of 4 months.
See also
  Status Clinical Trial Phase
Completed NCT02541175 - Multi-Channel Esophageal ECG Signal Classification N/A